Skip to main content
. 2017 Feb 10;12(2):e0171985. doi: 10.1371/journal.pone.0171985

Fig 4.

Fig 4

Kaplan–Meier survival curves showing that low ASS1 expression (ASS1-low) is associated reduced overall survival (p = 0.005, A) and disease-free survival (p = 0.001, B) compared to those whose tumors are ASS1-high in the untreated cohort. (C) and (D) Kaplan–Meier survival curves showing that ASS1-low is associated reduced overall survival (p = 0.04, C), but not disease-free survival (p = 0.13, D) compared to those whose tumors are ASS1-high in the treated cohort.